Myomo Inc Dossier
Qualitative Analysis
Business overview
Myomo, Inc. is a commercial-stage wearable medical robotics company specializing in myoelectric orthotics for people with neuromuscular disorders and upper-limb paralysis. The company designs, develops, and produces the MyoPro product line, which is a myoelectric-controlled upper limb brace (orthosis). By utilizing non-invasive sensors on the skin, the MyoPro senses a patient's own neurological signals to restore functional movement in weak or paralyzed arms and hands. This technology, originally developed at MIT in collaboration with medical experts from Harvard Medical School, serves patients suffering from stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, and other neurological conditions.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioning the go-to-market strategy from direct-to-consumer advertising to clinical partnerships with Orthotics and Prosthetics (O&P) clinics, highlighted by a nationwide distribution agreement with Ottobock Care clinics.
Expected impact: Establishes a highly scalable, recurring referral network that lowers customer acquisition costs and increases the percentage of revenue derived from recurring patient sources.
A field-based clinical program designed to engage patients earlier in their post-incidence recovery journey by partnering directly with therapists and physicians at rehabilitation hospitals.
Expected impact: Generates higher-quality patient candidates with significantly higher conversion rates and lower acquisition costs compared to traditional direct-to-consumer advertising.
Introduction of a proprietary mobile application that allows clinicians to manage MyoPro device settings remotely, replacing the previous requirement of shipping a dedicated laptop with pre-installed software.
Expected impact: Improves clinical workflow efficiency, enhances patient engagement, and directly reduces material cost of goods sold by eliminating laptop hardware from the product package.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
High. This multi-state agreement covers Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans, adding 45 million medical members to Myomo's addressable network and bringing total covered lives to over 80 million.
Terms: Provides in-network reimbursement rates for MyoPro devices, improving affordability for plan members and accelerating payment cycles.
High. Enables nationwide availability of the MyoPro powered arm brace across Ottobock's network of over 50 patient care centers in the United States.
Terms: Ottobock Care clinics will purchase and fit MyoPro devices for patients with upper extremity paralysis, expanding Myomo's O&P channel sales.
Medium. Established to manufacture and sell MyoPro products in the Greater China territory. However, the JV is currently on hold due to the bankruptcy of the majority shareholder's parent entity.
Terms: Myomo holds a 19.9% ownership stake. The JV is contractually obligated to purchase $10.75 million of MyoPro control system units over 10 years, subject to local regulatory approvals.